|
Billings, P C; Maki, P A; Kennedy, A R (1994) Effect of modifiers of arachidonic acid metabolism on radiation transformation and eicosanoid formation in C3H/10T1/2 cells. Cancer Biochem Biophys 14:211-20
|
|
Hughes, E N; Engelsberg, B N; Billings, P C (1992) Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2. J Biol Chem 267:13520-7
|
|
Billings, P C; Habres, J M (1992) A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Proc Natl Acad Sci U S A 89:3120-4
|
|
Habres, J M; Billings, P C (1992) Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors. Cancer Lett 63:135-42
|
|
Billings, P C; St Clair, W H; Maki, P A et al. (1992) Distribution of the Bowman Birk protease inhibitor in mice following oral administration. Cancer Lett 62:191-7
|
|
Billings, P C; Davis, R J; Engelsberg, B N et al. (1992) Characterization of high mobility group protein binding to cisplatin-damaged DNA. Biochem Biophys Res Commun 188:1286-94
|
|
Billings, P C; Jin, T; Ohnishi, N et al. (1991) The interaction of the potato-derived chymotrypsin inhibitor with C3H/10T1/2 cells. Carcinogenesis 12:653-7
|
|
Billings, P C; Brandon, D L; Habres, J M (1991) Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells. Eur J Cancer 27:903-8
|
|
Billings, P C; Habres, J M; Liao, D C et al. (1991) Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res 51:5539-43
|
|
Billings, P C; Habres, J M; Kennedy, A R (1990) Inhibition of radiation-induced transformation of C3H/10T1/2 cells by specific protease substrates. Carcinogenesis 11:329-32
|
Showing the most recent 10 out of 14 publications
